Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery), Care Setting (Hospital, Homecare) - Global Forecasts to 2026
[218 Pages Report] The global bone growth stimulator market size is projected to reach USD 1.5 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.8% during the forecast period. Various factors such as the growing patient preference for non-invasive and minimally invasive surgical treatments, the rising prevalence of target conditions, and the growing number of sports and accident-related orthopedic injuries are the key factors driving the growth of the bone growth stimulators market. However, limited medical reimbursement for bone stimulation devices, high treatment costs associated with BMP and PRP products, and side effects associated with BMP-based orthopedic treatment are the key factors restraining the growth of this market.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on the global bone growth stimulator market
The global COVID-19 pandemic has significantly impacted markets across multiple sectors and industries, such as healthcare, oil & petroleum, aeronautics & defense, and food & beverage. A majority of these industries are experiencing a period of uncertainty in terms of global economic conditions, the regional impact of the pandemic on business, government laws and preventive regulations, demand from end users, and challenges faced in the supply chain and logistics. As a result, key businesses and market players are forced to shift focus from long-term growth strategy to short-term sustainability tactics that have led to changes in business operations such as manufacturing, supplying, and consumer communication in certain sectors of the global economy.
The pandemic is expected to have a short-term negative impact on the bone growth stimulators market due to a sharp decline in elective surgeries, ban on organized sports, temporary closure of O&P clinics, hospital access restricted to non-essential care, limited access to clinics, and slow-down in-patient flow and referrals. However, gradual signs of recovery can be seen in key European markets as well as China. It is expected that the market will begin to gradually rise as expected from the late second half of 2021, which could be attributed to addressing pre-COVID elective surgeries, growing number of surgeries resulting from clearing backlogs as well as new cases, fully reopened healthcare services, recreation and physical work resumed on a large scale and the reopening of organized sports. Additionally, long-term growth drivers such as an increase in the geriatric population and the rising prevalence of diabetes, obesity, and osteoarthritis will continue to play a major role in the growth of the market during the forecast period.
BGS Market Dynamics
Driver: Growing patient preference for non-invasive and minimally invasive surgical treatments
The demand for minimally invasive procedures has witnessed a significant increase owing to the advantages offered by these procedures over traditional treatment procedures. The key advantages of minimally invasive procedures include fewer operative complications, shorter hospitalization, less pain, smaller and more cosmetic incisions, lower risk of infection, reduced postoperative care, and quicker recovery. Minimally invasive procedures make use of advanced technologies to diagnose and treat various diseases, including cancer. These procedures are used as an effective approach for removing cancer tumors and lymph nodes without scarring.
Restraint: Limited medical reimbursement for bone stimulation products
Medical reimbursement is among the major factors that affect the adoption and demand of specific diagnostic or therapeutic products among patients and healthcare providers at a country level. A majority of healthcare insurance providers in mature countries (such as the US and Australia) cover bone growth stimulation products under specific criteria. For instance, in the US, bone growth stimulation devices are covered under insurance if target bones are separated by less than 1 centimeter or are non-infected. Medicare (US) also covers bone growth stimulation devices under Part B schedule and offers device rent on prescription for specified indications. Similarly, the Transport Accident Commission (Australia) provides funding for implantable or externally applied bone growth stimulation equipment in case of transport accident injuries in the country. However, many private insurance providers do not include insurance or reimbursement for bone growth stimulation surgeries.
Opportunity: Emerging markets
Emerging economies (such as China, India, Brazil, and Mexico) are expected to offer significant growth opportunities in the bone growth stimulators market. Factors such as the presence of a large patient population, rising healthcare expenditure, government initiatives to support the healthcare industry, strengthening export trade, and growing awareness among physicians, surgeons, and patients about the latest treatment options for spinal fusion and bone healing are expected to boost the demand for bone growth stimulation products in these countries. In addition, owing to the significant cost advantages, many patients from developed markets are reported to travel to these emerging markets to undergo medical treatment.
Challenge: Side effects associated with BMP-based orthopedic treatment
Although BMPs are increasingly being used in spinal fusion and bone healing, they are associated with certain side effects. Tissue swelling, male infertility, and implant dislodgement are the major side effects associated with BMPs during spinal fusion surgery. During bone healing, BMPs are reported to cause antigenic reactions and stimulation of oncogenes. Medtronic reported several clinical complications associated with its BMP product during its use in spinal fusion surgeries for bone healing.
The bone growth stimulation devices segment to capture the largest share in the bone growth stimulator market, by product, during the forecast period
The bone growth stimulation devices segment accounted for the largest share of the bone growth stimulators market in 2021. This can be attributed to the growing geriatric population, rising preference for non-surgical treatment procedures, and growing prevalence of nonunion fractures. Additionally, obesity, smoking, and diabetes, among other factors, can delay or inhibit bone healing after surgery or trauma. The rising incidence of these risk factors will further aid market growth.
The spinal fusion surgeries segment to witness the highest growth rate in the bone growth stimulator market, by application in 2021
Spinal fusion surgeries are conducted to connect two or more vertebrae permanently and eliminate motion between them. Bone growth stimulation products are used during or post surgeries to stimulate the natural bone growth process. The growth of this segment can be attributed to the growing geriatric population, the rising number of spine procedures, the established safety and efficacy of stimulators in fusion surgery, and the increasing use of bone growth stimulation products.
The Hospitals segment accounted for the largest share of the bone growth stimulator, by end user, in 2021
Bone growth stimulation products are used in hospitals for various applications, including spine surgeries, oral and maxillofacial surgeries, dental practices, and bone fractures. Hospitals & ASCs accounted for the largest share of the bone growth stimulators market in 2021. The advantages of bone growth stimulation products over their counterparts, the rising patient population, growing procedural volumes of spinal fusion surgeries, growing prevalence of spinal disorders, and growing awareness on bone growth stimulation products are the key factors driving the growth of the bone growth stimulators market for hospitals & ASCs.
North America is the largest regional market for bone growth stimulator
North America accounted for the largest share of the bone growth stimulators market. The large share of North America can be attributed to the highly developed healthcare infrastructure and reimbursement system in the region and growing physician and patient awareness about the newly introduced treatment procedures and technologies in the market. The rising incidence of spinal disorders, increasing geriatric population, growing population exposure to key risk factors (such as obesity, smoking, and diabetes), and rising patient preference for minimally invasive orthopedic therapies are further driving the growth of the North American bone growth stimulators market.
Key Market Players
The prominent players operating in the global market include Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India) among others.
Orthofix Medical
Orthofix Medical is among the leading players in the bone stimulators market. The company plans to invest in basic science and clinical and evidence-based research to support broader indications for its stimulation products. The company’s portfolio of bone growth stimulators includes SpinalStim and CervicalStim. The CervicalStim stimulator is the only FDA-approved bone growth stimulator in the market used for cervical fusion. The company also focuses on R&D activities in collaboration with leading clinical organizations such as the Musculoskeletal Transplant Foundation (US), the Orthopedic Research and Education Foundation (US), and the Texas Scottish Rite Hospital for Children (US).
Scope of the report
|
Report Metric |
Details |
|
Market Size Available for Years |
2019–2026 |
|
Base Year Considered |
2020 |
|
Forecast Period |
2021–2026 |
|
Forecast Units |
Value (USD Billion) |
|
Segments Covered |
Product, modality, age group and region. |
|
Geographies Covered |
North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA |
|
Companies Covered |
Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India) |
This research report categorizes the Bone growth stimulator market based on product, application, end user and region.
By Product
- Bone Growth Stimulation Devices
- External Bone Growth Stimulators
- Capacitive Coupling Devices
- Combined Magnetic Field Devices
- Pulsed Electromagnetic Field Devices
- Implanted Bone Growth Stimulators
- Ultrasonic Bone Growth Stimulators
- Bone Morphogenetic Proteins
- Platelet-rich Plasma
By Application
- Spinal Fusion Surgeries
- Delayed Union & Nonunion Bone Fractures
- Oral & Maxillofacial Surgeries
- Other Applications
By End User
- Hospitals & ASCs
- Home Care Settings
- Academic & Research Institutes
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- RoEU
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
Recent Developments
- In 2021, Orthofix entered into an exclusive license agreement to commercialize the innovative portfolio of IGEA’s bone, cartilage, and soft tissue stimulation products in the US and Canada.
- In 2020, Stryker acquired Wright Medical for USD 5.4 billion. The acquisition strengthened Stryker’s position in the orthopedics devices market.
- In 2020, DePuy Synthes renewed its agreement with AO Foundation to improve patient care and outcomes through innovation and AO’s independent global education offerings.
Frequently Asked Questions (FAQ):
What are the drivers for the BGS market?
The growing patient preference for non-invasive and minimally invasive surgical treatments and increasing target patient population are the key factors driving the growth of the bone growth stimulators market.
Which segment provides the most opportunity for growth?
Among products, the bone growth stimulation devices segment will show the most opportunity for growth.
Who are the leading vendors operating in this market?
Orthofix (US), Zimmer Biomet (US), Bioventus LLC (US), DJO Finance, LLC (US), and Stryker (US).
Which region is expected to witness significant demand for BGS in the coming years?
The Asia Pacific is the fastest-growing geographic segment in BGS market, with a CAGR of 8.7% during the forecast period. The growth in this market is attributed to the presence of a large patient population, rising obesity rates, supportive government regulations, and rising disposable income levels in emerging APAC countries
What is the COVID 19 impact on BGS market in the coming years?
The pandemic is expected to have a short-term negative impact on the bone growth stimulators market due to a sharp decline in elective surgeries, ban on organized sports, temporary closure of O&P clinics, hospital access restricted to non-essential care, limited access to clinics, and slow-down in-patient flow and referrals. However, gradual signs of recovery can be seen in key European markets as well as China. It is expected that the market will begin to gradually rise as expected from the late second half of 2021, which could be attributed to addressing pre-COVID elective surgeries, growing number of surgeries resulting from clearing backlogs as well as new cases, fully reopened healthcare services, recreation and physical work resumed on a large scale, and the reopening of organized sports. Additionally, long-term growth drivers such as an increase in the geriatric population and the rising prevalence of diabetes, obesity, and osteoarthritis will continue to play a major role in the growth of the market during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.4.1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY RESEARCH
FIGURE 2 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PRODUCT-BASED MARKET ESTIMATION
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 COVID-19 HEALTH ASSESSMENT
2.4 COVID-19 ECONOMIC ASSESSMENT
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 8 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.6 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION
2.7 RESEARCH ASSUMPTIONS
2.8 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 BONE GROWTH STIMULATORS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE BONE GROWTH STIMULATORS MARKET
4 PREMIUM INSIGHTS (Page No. - 49)
4.1 BONE GROWTH STIMULATORS MARKET OVERVIEW
FIGURE 14 RISING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE MARKET GROWTH
4.2 BONE GROWTH STIMULATORS MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 15 HOSPITALS & ASCS SEGMENT WILL CONTINUE TO DOMINATE THE BONE GROWTH STIMULATORS MARKET IN 2026
4.3 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT & COUNTRY (2020)
FIGURE 16 BONE GROWTH STIMULATION DEVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.4 BONE GROWTH STIMULATORS MARKET, BY REGION, 2021‒2026
FIGURE 17 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MAJOR MARKET DRIVERS
5.2.1.1 Growing patient preference for noninvasive and minimally invasive surgical treatments
5.2.1.2 Increasing target patient population
FIGURE 18 OBESE POPULATION (AS A PERCENTAGE OF THE TOTAL POPULATION) IN OECD COUNTRIES (2017)
5.2.1.3 Rising number of sports and accident-related orthopedic injuries
FIGURE 19 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US (2019)
FIGURE 20 JAPAN REPORTED THE HIGHEST NUMBER OF ROAD ACCIDENTS GLOBALLY (2019)
5.2.2 MAJOR MARKET RESTRAINTS
5.2.2.1 Limited medical reimbursement for bone stimulation products
5.2.2.2 High treatment costs associated with BMP and PRP products
5.2.2.3 Limited clinical evidence to support the therapeutic efficacy of bone growth stimulators
5.2.3 MAJOR MARKET OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.4 MAJOR MARKET CHALLENGES
5.2.4.1 Side effects associated with BMP-based orthopedic treatment
TABLE 1 CLINICAL SIDE EFFECTS ASSOCIATED WITH BMP-2
TABLE 2 PRECLINICAL SIDE EFFECTS WITH BMP-2 (IN VITRO AND IN VIVO)
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 OVERVIEW
TABLE 3 BONE GROWTH STIMULATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.2 THREAT OF NEW ENTRANTS
FIGURE 21 THREAT OF NEW ENTRANTS
5.3.3 THREAT OF SUBSTITUTES
FIGURE 22 THREAT OF SUBSTITUTES
5.3.4 BARGAINING POWER OF SUPPLIERS
FIGURE 23 BARGAINING POWER OF SUPPLIERS
5.3.5 BARGAINING POWER OF BUYERS
FIGURE 24 BARGAINING POWER OF BUYERS
5.3.6 DEGREE OF COMPETITION
FIGURE 25 DEGREE OF COMPETITION
5.4 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS—MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
FIGURE 27 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 REGULATORY ANALYSIS
5.7.1 NORTH AMERICA
5.7.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.7.1.2 Canada
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 28 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.7.2 EUROPE
FIGURE 29 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.7.3 ASIA PACIFIC
5.7.3.1 Japan
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.7.3.2 China
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.7.3.3 India
5.8 TECHNOLOGY ANALYSIS
5.9 PATENT DETAILS
FIGURE 30 PATENT ANALYSIS (JANUARY 2011–MARCH 2021)
5.10 COVID-19 IMPACT ON THE BONE GROWTH STIMULATORS MARKET
5.11 PRICING ANALYSIS
TABLE 9 PRICING ANALYSIS: BONE GROWTH STIMULATORS, 2019 (USD)
6 BONE GROWTH STIMULATORS MARKET, BY PRODUCT (Page No. - 78)
6.1 INTRODUCTION
TABLE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 BONE GROWTH STIMULATION DEVICES
TABLE 11 BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 12 BONE GROWTH STIMULATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 13 BONE GROWTH STIMULATION DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 14 BONE GROWTH STIMULATION DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
6.2.1 EXTERNAL BONE GROWTH STIMULATORS
TABLE 15 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 16 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 17 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 18 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
6.2.1.1 Pulsed electromagnetic field devices
6.2.1.1.1 Pulsed electromagnetic field devices to witness the highest growth in the external bone growth stimulators market
TABLE 19 PULSED ELECTROMAGNETIC FIELD DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.2 Combined magnetic field devices
6.2.1.2.1 Combined magnetic field devices are portable, battery-powered, and noninvasive
TABLE 20 COMBINED MAGNETIC FIELD DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.3 Capacitive coupling devices
6.2.1.3.1 Need for frequent battery replacement or recharge is a disadvantage associated with CC devices
TABLE 21 CAPACITIVE COUPLING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 ULTRASONIC BONE GROWTH STIMULATORS
6.2.2.1 These stimulators are used in the treatment of nonunion bone fractures and failed arthrodesis
TABLE 22 HCPCS CODE
TABLE 23 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 24 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 25 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
6.2.3 IMPLANTED BONE GROWTH STIMULATORS
6.2.3.1 Implanted bone growth stimulators provide constant stimulation of the bone directly at the fracture site and increase patient compliance
TABLE 26 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 27 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 28 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
6.3 BONE MORPHOGENETIC PROTEINS
6.3.1 BMP IS A SAFE AND EFFECTIVE ALTERNATIVE TO BONE GRAFTS
TABLE 29 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 30 BONE MORPHOGENETIC PROTEINS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 31 BONE MORPHOGENETIC PROTEINS MARKET, BY END USER, 2019–2026 (USD MILLION)
6.4 PLATELET-RICH PLASMA
6.4.1 ADVANTAGES OF PRP OVER OTHER PRODUCTS USED IN BONE STIMULATION TO DRIVE MARKET GROWTH
TABLE 32 PLATELET-RICH PLASMA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 33 PLATELET-RICH PLASMA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 34 PLATELET-RICH PLASMA MARKET, BY END USER, 2019–2026 (USD MILLION)
7 BONE GROWTH STIMULATORS MARKET, BY APPLICATION (Page No. - 96)
7.1 INTRODUCTION
TABLE 35 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 SPINAL FUSION SURGERIES
7.2.1 SPINAL FUSION SURGERIES TO DOMINATE THE BONE GROWTH STIMULATORS MARKET
TABLE 36 BONE GROWTH STIMULATORS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2019–2026 (USD MILLION)
7.3 DELAYED UNION & NONUNION BONE FRACTURES
7.3.1 NONUNION FRACTURES ARE ESTIMATED TO COST THE US HEALTHCARE SYSTEM USD 9.2 BILLION/YEAR
TABLE 37 BONE GROWTH STIMULATORS MARKET FOR DELAYED UNION & NONUNION BONE FRACTURES, BY REGION, 2019–2026 (USD MILLION)
7.4 ORAL & MAXILLOFACIAL SURGERIES
7.4.1 BMPS ARE USED IN ORAL & MAXILLOFACIAL SURGERIES TO FORM A BASE FOR THE DENTAL IMPLANT AND STRENGTHEN AND THICKEN DENTAL SITES
TABLE 38 BONE GROWTH STIMULATORS MARKET FOR ORAL & MAXILLOFACIAL SURGERIES, BY REGION, 2019–2026 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 39 BONE GROWTH STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
8 BONE GROWTH STIMULATORS MARKET, BY END USER (Page No. - 102)
8.1 INTRODUCTION
TABLE 40 BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 HOSPITALS & ASCS
8.2.1 HOSPITALS & ASCS ARE THE LARGEST & FASTEST-GROWING END USERS OF BONE GROWTH STIMULATORS
TABLE 41 BONE GROWTH STIMULATORS MARKET FOR HOSPITALS & ASCS, BY REGION, 2019–2026 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH
TABLE 42 BONE GROWTH STIMULATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2019–2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING RESEARCH ON BONE GROWTH STIMULATION PRODUCTS TO AID MARKET GROWTH
TABLE 43 BONE GROWTH STIMULATORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
9 BONE GROWTH STIMULATORS MARKET, BY REGION (Page No. - 108)
9.1 INTRODUCTION
TABLE 44 BONE GROWTH STIMULATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 31 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 46 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 47 NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 48 NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 50 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 High burden of sports-related injuries and the strong presence of market players will drive market growth in the US
TABLE 51 US: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 52 US: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 US: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Market growth is driven by the rising incidence of bone-related diseases
TABLE 54 CANADA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 55 CANADA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 CANADA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 57 EUROPE: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 58 EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany is the largest market for bone growth stimulators in Europe
TABLE 63 GERMANY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 GERMANY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 GERMANY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Market growth in the UK is driven by the increasing funding by public and private organizations
TABLE 66 UK: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 UK: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 UK: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising prevalence of diabetes to support market growth
TABLE 69 FRANCE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 70 FRANCE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 FRANCE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing market availability of high-end bone growth stimulators to drive market growth
TABLE 72 ITALY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 73 ITALY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 74 ITALY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing geriatric population and the subsequent increase in the prevalence of target conditions to drive market growth
TABLE 75 SPAIN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 76 SPAIN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 SPAIN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 78 ROE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 79 ROE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 ROE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 81 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 82 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 86 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Japan dominates the Asia Pacific bone growth stimulators market
TABLE 87 JAPAN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 JAPAN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 JAPAN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Expansion in target patient population and modernization of healthcare facilities to drive the market growth
TABLE 90 CHINA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 91 CHINA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 CHINA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing number of orthopedic surgeries to support market growth
TABLE 93 INDIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 94 INDIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 INDIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Availability of grants for the development of a comprehensive range of advanced treatments to support market growth
TABLE 96 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 97 AUSTRALIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 AUSTRALIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives will positively impact market growth
TABLE 99 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 100 SOUTH KOREA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 SOUTH KOREA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 102 ROAPAC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 103 ROAPAC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 ROAPAC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 105 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 106 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 110 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Modernization of healthcare facilities will drive market growth
TABLE 111 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 112 BRAZIL: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 BRAZIL: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
TABLE 114 MEXICO: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 115 MEXICO: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 MEXICO: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 117 ROLATAM: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 118 ROLATAM: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ROLATAM: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 AWARENESS INITIATIVES TO DRIVE THE ADOPTION OF BONE GROWTH STIMULATORS IN THE REGION
TABLE 120 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 164)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
TABLE 125 OVERVIEW OF STRATEGIES DEPLOYED BY KEY BONE GROWTH STIMULATOR MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 33 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 34 BONE GROWTH STIMULATORS MARKET SHARE, BY KEY PLAYER, 2020
10.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 126 BONE GROWTH STIMULATORS MARKET: DEGREE OF COMPETITION
10.6 COMPETITIVE LEADERSHIP MAPPING
10.7 VENDOR INCLUSION CRITERIA
10.7.1 STARS
10.7.2 EMERGING LEADERS
10.7.3 PERVASIVE PLAYERS
10.7.4 PARTICIPANTS
FIGURE 35 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.8 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
10.8.1 PROGRESSIVE COMPANIES
10.8.2 STARTING BLOCKS
10.8.3 RESPONSIVE COMPANIES
10.8.4 DYNAMIC COMPANIES
FIGURE 36 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
10.9 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
10.9.1 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
TABLE 127 COMPANY PRODUCT FOOTPRINT
TABLE 128 COMPANY REGIONAL FOOTPRINT
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES
TABLE 129 KEY PRODUCT LAUNCHES, JANUARY 2017–JUNE 2021
10.10.2 DEALS
TABLE 130 KEY DEALS, JANUARY 2017–JUNE 2021
10.10.3 OTHER DEVELOPMENTS
TABLE 131 OTHER DEVELOPMENTS, JANUARY 2017–JUNE 2021
11 COMPANY PROFILES (Page No. - 178)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 KEY PLAYERS
11.1.1 ORTHOFIX MEDICAL, INC.
TABLE 132 ORTHOFIX MEDICAL, INC.: BUSINESS OVERVIEW
FIGURE 37 ORTHOFIX, MEDICAL INC.: COMPANY SNAPSHOT (2020)
11.1.2 DEPUY SYNTHES
TABLE 133 DEPUY SYNTHES: BUSINESS OVERVIEW
FIGURE 38 DEPUY SYNTHES: COMPANY SNAPSHOT (2020)
11.1.3 STRYKER
TABLE 134 STRYKER: BUSINESS OVERVIEW
FIGURE 39 STRYKER: COMPANY SNAPSHOT (2020)
11.1.4 BIOVENTUS LLC
TABLE 135 BIOVENTUS LLC: BUSINESS OVERVIEW
FIGURE 40 BIOVENTUS LLC: COMPANY SNAPSHOT (2020)
11.1.5 MEDTRONIC PLC
TABLE 136 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.6 DJO FINANCE, LLC
TABLE 137 DJO FINANCE, LLC: BUSINESS OVERVIEW
11.1.7 ZIMMER BIOMET
TABLE 138 ZIMMER BIOMET: BUSINESS OVERVIEW
FIGURE 42 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
11.1.8 ARTHREX, INC.
TABLE 139 ARTHREX, INC.: BUSINESS OVERVIEW
11.1.9 TERUMO CORPORATION
TABLE 140 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 43 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
11.1.10 OSSATEC BENELUX LTD.
TABLE 141 OSSATEC BENELUX LTD.: BUSINESS OVERVIEW
11.1.11 ISTO BIOLOGICS
TABLE 142 ISTO BIOLOGICS: BUSINESS OVERVIEW
11.1.12 EMBER THERAPEUTICS, INC.
TABLE 143 EMBER THERAPEUTICS, INC.: BUSINESS OVERVIEW
11.1.13 REGEN LAB SA
TABLE 144 REGEN LAB SA: BUSINESS OVERVIEW
11.1.14 ALTIS BIOLOGICS (PTY) LTD.
TABLE 145 ALTIS BIOLOGICS (PTY) LTD.: BUSINESS OVERVIEW
11.1.15 ITO CO., LTD.
TABLE 146 ITO CO., LTD.: BUSINESS OVERVIEW
11.2 OTHER COMPANIES
11.2.1 ELIZUR CORPORATION
11.2.2 BTT HEALTH GMBH
11.2.3 STIMULATE HEALTH
11.2.4 VQ ORTHOCARE
11.2.5 KINEX MEDICAL COMPANY, LLC
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 210)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
The study involved four major activities to estimate the current size of the bone growth stimulators market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulatory bodies, and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), American Association of Orthopedics (AAOS), American Trauma Association (ATS), European Society for Trauma and Emergency Services (ESTES) were referred to identify and collect information for the bone growth stimulator market study.
Primary Research
The bone growth stimulator market comprises several stakeholders such as product manufacturing companies, market research and consulting firms. The demand side of this market is characterized by the increasing numbers of hospital, ambulatory surgical centers, clinics, academic research institutes, and increased in number of players in the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the bone growth stimulator market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall size of the global Bone growth stimulator market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Report Objectives
- To define, describe, and forecast the global bone growth stimulators market on the basis of product, application, and end user
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
- To profile the key players and comprehensively analyze their market shares and core competencies2
- To track and analyze competitive developments such as product launches, agreements, partnerships, collaborations, expansions, and acquisitions in the bone growth stimulators market
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the global Bone growth stimulator market report
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players.
Company Information
- Detailed analysis and profiling of additional market players (up to 5 OEMs)
Geographic Analysis
- Further breakdown of the Rest of Europe BGS market into Belgium, Austria,
- Denmark, Greece, Poland, and Russia, among other countries
- Further breakdown of the Rest of Asia Pacific BGS market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
- Further breakdown of the Rest of Latin America BGS market into Argentina, and Colombia, among other countries.
Get in-depth analysis of the COVID-19 impact on the Bone Growth Stimulator Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Bone Growth Stimulator Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Bone Growth Stimulator Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Bone Growth Stimulator Market